← All companies

JSPR

Jasper Therapeutics, Inc.

JSPRW Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.01

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$297K

Revenue (TTM)

—

Net income (TTM)

$20.1M

EPS (TTM)

$-2.58

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$14.1M

Total assets

$21.2M

Gross margin

—

52-week range

$0.01 – $0.01

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Aug 3, 2026 8-K Other events Jul 31, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jul 17, 2026 8-K Regulation FD disclosure Jul 16, 2026 8-K Delisting notice or listing-rule failure Jun 9, 2026 8-K Regulation FD disclosure Jun 1, 2026 8-K Director or officer change May 21, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Other events Jan 8, 2026 8-K Director or officer change; Other events Jan 7, 2026 8-K Other events Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Entered a material agreement; Other events Sep 19, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Exit or disposal costs; Director or officer change; Other events Jul 9, 2025 8-K Other events Jul 7, 2025 8-K Shareholder vote results Jul 3, 2025 8-K Other events Jun 16, 2025 8-K Results of operations (earnings release) May 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Entered a material agreement; Terminated a material agreement Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Other events Jan 8, 2025 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Other events Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change; Other events Jun 20, 2024 8-K Director or officer change; Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release) Mar 4, 2024 8-K Entered a material agreement; Other events Feb 6, 2024